StockData
Latigo Biotherapeutics, Inc. logo

Latigo Biotherapeutics, Inc. (LTGO) stock

LTGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026
$13.31−0.45 (-3.27%)

Close on Nov 18, 2026Market cap $882.44MP/E –Yield 0.00%

Latigo Biotherapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Latigo Biotherapeutics's shares outstanding was 38M at Sep 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202638M–
Q2 FY2026Jun 30, 20261M–
Q3 FY2025Sep 30, 20251M–
Q2 FY2025Jun 30, 20251M–

More Latigo Biotherapeutics figures

See a number that looks wrong?